ketoconazole and crizotinib

ketoconazole has been researched along with crizotinib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Johnson, TR; Smith, BJ; Yamazaki, S	1
Bello, A; Brega, N; O'Gorman, M; Tan, W; Xu, H	1
Cheng, B; Cheng, S; Kafle, OP; Li, P; Liang, C; Liu, L; Ma, M; Qi, X; Wen, Y; Zhang, F; Zhang, L	1

Trials

2 trial(s) available for ketoconazole and crizotinib

Article	Year
Prediction of Drug-Drug Interactions with Crizotinib as the CYP3A Substrate Using a Physiologically Based Pharmacokinetic Model. Drug metabolism and disposition: the biological fate of chemicals, 2015, Volume: 43, Issue:10 Topics: Adult; Crizotinib; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Female; Forecasting; Humans; Ketoconazole; Male; Middle Aged; Models, Biological; Pyrazoles; Pyridines; Rifampin; Substrate Specificity	2015
The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects. European journal of clinical pharmacology, 2015, Volume: 71, Issue:12 Topics: Adult; Area Under Curve; Crizotinib; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Middle Aged; Pyrazoles; Pyridines; Rifampin	2015

Article

Year

Prediction of Drug-Drug Interactions with Crizotinib as the CYP3A Substrate Using a Physiologically Based Pharmacokinetic Model.

Drug metabolism and disposition: the biological fate of chemicals, 2015, Volume: 43, Issue:10

Topics: Adult; Crizotinib; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Female; Forecasting; Humans; Ketoconazole; Male; Middle Aged; Models, Biological; Pyrazoles; Pyridines; Rifampin; Substrate Specificity

2015

The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects.

European journal of clinical pharmacology, 2015, Volume: 71, Issue:12

Topics: Adult; Area Under Curve; Crizotinib; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Middle Aged; Pyrazoles; Pyridines; Rifampin

2015

Other Studies

1 other study(ies) available for ketoconazole and crizotinib

Article	Year
CGSEA: A Flexible Tool for Evaluating the Associations of Chemicals with Complex Diseases. G3 (Bethesda, Md.), 2020, 03-05, Volume: 10, Issue:3 Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Crizotinib; Ethoxyquin; Female; Gene Expression; Genome-Wide Association Study; Humans; Indans; Indoles; Ketoconazole; Methylazoxymethanol Acetate; Sesquiterpenes; Software; Toluidines; Uranium; Uterine Cervical Neoplasms; Vitamin E	2020

Article

Year

CGSEA: A Flexible Tool for Evaluating the Associations of Chemicals with Complex Diseases.

G3 (Bethesda, Md.), 2020, 03-05, Volume: 10, Issue:3

Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Crizotinib; Ethoxyquin; Female; Gene Expression; Genome-Wide Association Study; Humans; Indans; Indoles; Ketoconazole; Methylazoxymethanol Acetate; Sesquiterpenes; Software; Toluidines; Uranium; Uterine Cervical Neoplasms; Vitamin E

2020